CVRx (CVRX) Quality Rank


CVRX CVRx Inc CVRX
56 GF Score
Price $5.60
GF Value $11.25
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is CVRx Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

CVRx Quality Rank Related Terms

CVRX
56GF Score
CVRx Inc CVRX
Quality Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is CVRx (CVRX) Overvalued in 2026?

Based on GuruFocus' analysis, CVRx stock appears to be undervalued. The current stock price of $5.60 is trading 50.3% below its estimated GF Value™ of $11.25. GuruFocus considers CVRx to be Possible Value Trap.

Key valuation signals for CVRX:

  • Quality Rank:
  • GF Value™: $11.25 vs. price of $5.60 (50.3% below fair value)
  • GF Score™: 56/100 with 4 warning signs

No single metric tells the full story. See the CVRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CVRx Business Description

Address 9201 West Broadway Avenue, Suite 650, Minneapolis, MN, USA, 55445
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
56GF Score

Get the complete analysis for CVRX

Quality Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.60
Price
$11.25
GF Value